Encyclopedia

  • Preclinical ResearchMalonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction
  • Add time:09/07/2019         Source:sciencedirect.com

    SummaryAlterations in cardiac energy metabolism after a myocardial infarction contribute to the severity of heart failure (HF). Although fatty acid oxidation can be impaired in HF, it is unclear if stimulating fatty acid oxidation is a desirable approach to treat HF. Both immediate and chronic malonyl coenzyme A decarboxylase inhibition, which decreases fatty acid oxidation, improved cardiac function through enhancing cardiac efficiency in a post–myocardial infarction rat that underwent permanent left anterior descending coronary artery ligation. The beneficial effects of MCD inhibition were attributed to a decrease in proton production due to an improved coupling between glycolysis and glucose oxidation.

    We also recommend Trading Suppliers and Manufacturers of Malonyl chloride (cas 1663-67-8). Pls Click Website Link as below: cas 1663-67-8 suppliers


    Prev:Research articleImpact of sporicidal fumigation with methyl bromide or methyl iodide on electronic equipment
    Next: Anorexic behavior and elevation of hypothalamic malonyl-CoA in socially defeated rats)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View